Company / R&D Expense
VOLITIONRX LTD R&D Expense History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$14.4M
FY2025
5-year range
$13.0M / $19.6M
FY2021-FY2025
Trend
-26.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $2M in FY2012 to $20M in FY2024.
Based on SEC 10-K filings.
$14M in FY2025 with a 5-year CAGR of +6.8%.
Declined from $15M to $14M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, r&d expense decreased 26.3% year-over-year.
- Peak r&d expense was recorded in FY2024.
- Lowest r&d expense in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.4M | -26.3% |
| FY2024 | $19.6M | +27.5% |
| FY2023 | $15.3M | +17.7% |
| FY2022 | $13.0M | -10.4% |
| FY2021 | $14.5M | +40.2% |
| FY2020 | $10.4M | -5.0% |
| FY2019 | $10.9M | +335.6% |
| FY2014 | $2.5M | -9.7% |
| FY2013 | $2.8M | +82.3% |
| FY2012 | $1.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026